Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
EMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Genome Med. 2018 Oct 24;10(1):76. doi: 10.1186/s13073-018-0589-3.
The IRE1a-XBP1 pathway is a conserved adaptive mediator of the unfolded protein response. The pathway is indispensable for the development of secretory cells by facilitating protein folding and enhancing secretory capacity. In the immune system, it is known to function in dendritic cells, plasma cells, and eosinophil development and differentiation, while its role in T helper cell is unexplored. Here, we investigated the role of the IRE1a-XBP1 pathway in regulating activation and differentiation of type-2 T helper cell (Th2), a major T helper cell type involved in allergy, asthma, helminth infection, pregnancy, and tumor immunosuppression.
We perturbed the IRE1a-XBP1 pathway and interrogated its role in Th2 cell differentiation. We performed genome-wide transcriptomic analysis of differential gene expression to reveal IRE1a-XBP1 pathway-regulated genes and predict their biological role. To identify direct target genes of XBP1 and define XBP1's regulatory network, we performed XBP1 ChIPmentation (ChIP-seq). We validated our predictions by flow cytometry, ELISA, and qPCR. We also used a fluorescent ubiquitin cell cycle indicator mouse to demonstrate the role of XBP1 in the cell cycle.
We show that Th2 lymphocytes induce the IRE1a-XBP1 pathway during in vitro and in vivo activation. Genome-wide transcriptomic analysis of differential gene expression by perturbing the IRE1a-XBP1 pathway reveals XBP1-controlled genes and biological pathways. Performing XBP1 ChIPmentation (ChIP-seq) and integrating with transcriptomic data, we identify XBP1-controlled direct target genes and its transcriptional regulatory network. We observed that the IRE1a-XBP1 pathway controls cytokine secretion and the expression of two Th2 signature cytokines, IL13 and IL5. We also discovered that the IRE1a-XBP1 pathway facilitates activation-dependent Th2 cell proliferation by facilitating cell cycle progression through S and G2/M phase.
We confirm and detail the critical role of the IRE1a-XBP1 pathway during Th2 lymphocyte activation in regulating cytokine expression, secretion, and cell proliferation. Our high-quality genome-wide XBP1 ChIP and gene expression data provide a rich resource for investigating XBP1-regulated genes. We provide a browsable online database available at http://data.teichlab.org .
IRE1a-XBP1 通路是未折叠蛋白反应的一种保守的适应性介质。该途径对于分泌细胞的发育是必不可少的,它促进蛋白质折叠并增强分泌能力。在免疫系统中,它已知在树突状细胞、浆细胞和嗜酸性粒细胞的发育和分化中起作用,而其在辅助性 T 细胞中的作用尚未被探索。在这里,我们研究了 IRE1a-XBP1 途径在调节 2 型辅助性 T 细胞(Th2)的激活和分化中的作用,Th2 是一种主要的辅助性 T 细胞类型,参与过敏、哮喘、寄生虫感染、妊娠和肿瘤免疫抑制。
我们干扰 IRE1a-XBP1 途径,并研究其在 Th2 细胞分化中的作用。我们进行了全基因组转录组分析,以揭示 IRE1a-XBP1 途径调控的基因,并预测其生物学作用。为了鉴定 XBP1 的直接靶基因并定义 XBP1 的调控网络,我们进行了 XBP1 ChIPmentation(ChIP-seq)。我们通过流式细胞术、ELISA 和 qPCR 验证了我们的预测。我们还使用荧光泛素细胞周期指示剂小鼠来证明 XBP1 在细胞周期中的作用。
我们表明,Th2 淋巴细胞在体外和体内激活过程中诱导 IRE1a-XBP1 途径。通过干扰 IRE1a-XBP1 途径进行全基因组转录组分析揭示了 XBP1 控制的基因和生物学途径。进行 XBP1 ChIPmentation(ChIP-seq)并与转录组数据整合,我们鉴定了 XBP1 控制的直接靶基因及其转录调控网络。我们观察到 IRE1a-XBP1 途径通过促进 S 和 G2/M 期的细胞周期进程来控制细胞增殖,从而控制细胞因子的分泌和两种 Th2 特征细胞因子(IL13 和 IL5)的表达。我们还发现 IRE1a-XBP1 途径通过促进激活依赖性 Th2 细胞增殖在 Th2 淋巴细胞激活过程中发挥关键作用。
我们证实并详细说明了 IRE1a-XBP1 途径在调节 Th2 淋巴细胞激活过程中细胞因子表达、分泌和细胞增殖中的关键作用。我们高质量的全基因组 XBP1 ChIP 和基因表达数据为研究 XBP1 调控的基因提供了丰富的资源。我们提供了一个可浏览的在线数据库,可在 http://data.teichlab.org 上获得。